4 stocks to watch on Wednesday: CRWD, GRFS and more

U.S. stock index futures on Wednesday were little changed, as market participants received a flurry of economic data and awaited a key inflation reading. Here are some stocks to watch on Wednesday:

• Class A shares of CrowdStrike (CRWD) fell nearly 2% in pre-market trading, despite the cybersecurity firm raising its annual top- and bottom-line guidance. This was CRWD’s second quarterly report since a faulty update it issued in July led to a historic worldwide IT outage that affected millions of Microsoft (MSFT) Windows devices. The company’s FQ3 2025 results indicated that it had moved past the summer outage incident, as its annual recurring revenue grew 27% Y/Y to $4.02B. The midpoint of CrowdStrike’s (CRWD) FQ4 revenue guidance range came in a whisker above the consensus estimate. See how CRWD performed in charts.
• Nordstrom (JWN) stock fell around 0.6% ahead of the opening bell, despite the department store chain delivering a 4% rise in Q3 comparable sales and raising the lower end of its annual revenue and comparable sales guidance ranges. “While we are excited about and well-prepared for the holiday season, there was a noticeable decline in sales trends towards the end of October,” top boss Erik Nordstrom said in prepared remarks, while finance chief Cathy Smith noted that the “external environment remains uncertain.”
• Apple (AAPL) stock was in focus, down about 0.6% ahead of market open. According to Reuters, official data from China showed foreign branded smartphone sales plunging 44.25% Y/Y in October. A bulk of the foreign smartphone market in the Asian nation is dominated by Apple (AAPL). China has long been a key focus for investors in the tech giant, and the Tim Cook-led company has often faced an uphill battle in terms of sales in the country. The Greater China region drew in $15.03B in revenue in Apple’s (AAPL) latest quarterly results.
• U.S.-listed shares of Grifols (GRFS) slumped more than 12% in pre-market trading. The move came after multiple media reports said that Canadian asset manager Brookfield (BAM) had dropped its plans to take the Spanish healthcare firm private. Reuters said disagreements over Grifols’ (GRFS) valuation led to the decision. Last week, Grifols’ (GRFS) board had declined to recommend Brookfield’s (BAM) preliminary offer, which valued GRFS at €6.45B ($6.82B). Meanwhile, Bloomberg News said the Grifols (GRFS) family would not back another take-private deal.